Russian govt calls on regions to establish four-month drugs reserve

8 December 2022
russia_flag_sky_big

The crisis in the Russian pharmaceutical sector is deepening as the country’s Ministry of Health has officially called on the regions to form a four-month reserve of drugs, which is mainly due to the possible interruptions in their supplies from abroad, reports The Pharma Letter’s local correspondent.

Despite the fact that most global drugmakers continue supplies of their drugs to Russia, which has had Western sanctions imposed on it following its invasion of Ukraine, it has become more difficult for them to do so.

In order to prevent any possible shortages the Russian Ministry of Health has given strict instructions to all the regions of  the country to form a sufficient amount of the drugs - at least four months of stock.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical